CE Opportunities By Credit Type

CE Opportunities

By Credit Type

AAPA

CIS: Treating or Not Treating and with What?

DATE OF RELEASE/EXPIRATION The enduring material will be available from...

Young Latina MS Patient and Family Planning

DATE OF RELEASE/EXPIRATION The enduring material will be available from...

MANAGEMENT OF MS IN AFRICAN AMERICANS/BLACKS

DATE OF RELEASE/EXPIRATION The enduring material will be available from...

TREATMENT APPROACHES IN MS: CRITERIA FOR DECISION MAKING

DATE OF RELEASE/EXPIRATION The enduring material will be available from...

RACIAL AND GENETIC IMPLICATIONS FOR MS TREATMENT SELECTION

DATE OF RELEASE/EXPIRATION The enduring material will be available from...

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 1: Fundamentals of Cannabis

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION...

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 2: Cannabis as an Herbal Medicine – Efficacy/Side Effect Considerations and Case Studies

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION...

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 3: Pharmacology and Interactions, Trial Data, DMTs, and Case Studies

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION...

5-Part Podcast Series: Recent Clinical Updates in the Management of Multiple Sclerosis

Earn 1.25 AMA PRA Category 1 Credit(s)™, 1.25 contact hours for...

Therapeutic Advances in the Management of Relapsing Forms of Multiple Sclerosis

Release Date: 3/12/2021 Expiration Date: 3/11/2022 Provider Statement This continuing...

Multiple Sclerosis Management in Primary Care

Release Date: October 29, 2021 Expiration Date: October 28, 2022 Program Description...

A 3D Virtual Symposium Patient Considerations in MS: Achieving Optimal Outcomes Through an Individualized, Comprehensive Approach

Wednesday, February 16, 2022 7:00 PM (ET); 6:00 PM (CT);...

Multiple Sclerosis Management: Shedding Light on the Patient Perspective

Course opens: 12/20/2021 Course expires: 12/21/2022 Overview This activity, originally...

ForuMS: Highlights from the 2021 CMSC Annual Meeting

Thursday, February 10, 2022 6:30 pm – 8:00 pm EST With...

CIS: Treating or Not Treating and with What?

DATE OF RELEASE/EXPIRATION The enduring material will be available from...

Young Latina MS Patient and Family Planning

DATE OF RELEASE/EXPIRATION The enduring material will be available from...

MANAGEMENT OF MS IN AFRICAN AMERICANS/BLACKS

DATE OF RELEASE/EXPIRATION The enduring material will be available from...

TREATMENT APPROACHES IN MS: CRITERIA FOR DECISION MAKING

DATE OF RELEASE/EXPIRATION The enduring material will be available from...

RACIAL AND GENETIC IMPLICATIONS FOR MS TREATMENT SELECTION

DATE OF RELEASE/EXPIRATION The enduring material will be available from...

Neuromyelitis Optica Spectrum Disorder: Modern Approaches to Diagnosis and Treatment

RELEASED ON: December 31, 2021EXPIRES ON: December 31, 2022This activity...

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 1: Fundamentals of Cannabis

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION...

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 2: Cannabis as an Herbal Medicine – Efficacy/Side Effect Considerations and Case Studies

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION...

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 3: Pharmacology and Interactions, Trial Data, DMTs, and Case Studies

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION...

Science and Self: Monitoring Response to MS Treatment with Biomarkers and Patient-Reported Outcomes

Release: 12/15/21 Expiration: 12/15/22 This activity is jointly provided by The...

Right Treatment, Right Time: A Comprehensive Curriculum on Individualized Treatment Approaches for Multiple Sclerosis

Released: December 1, 2021 Expires: December 1, 2022 An informative...

IJMSC: NARCOMS and Other Registries in Multiple Sclerosis: Issues and Insights

Release Date: December 1, 2021 Valid for Credit Through: December...

Novel Treatment: Upgrading the Standard of Care for Neuromyelitis Optica Spectrum Disorder (NMOSD)

RELEASE DATE: November 18, 2021 EXPIRATION DATE: November 18, 2022 FACULTY Dean...

1,800 Seconds™ in Vaccines and MS Treatment

Release Date: October 7, 2021 Valid for Credit Through: October...

IJMSC: Evaluation of Treatment Practices for Urinalyses and Urine Cultures at an Outpatient Multiple Sclerosis Clinic

Release Date: October 1, 2021 Valid for Credit Through: October...

Medical Minute: Influence of Sleep Disturbances and Obesity on MS and Associated Symptoms

Physicians: maximum of 0.5 AMA PRA Category 1 Credits™Registered Nurses:...

Medical Minute: Influence of Anxiety and Depression on MS and Associated Symptoms

Physicians: maximum of 0.5 AMA PRA Category 1 Credits™Registered Nurses:...

The Importance of Managing Fatigue in Multiple Sclerosis

Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered...

5-Part Podcast Series: Recent Clinical Updates in the Management of Multiple Sclerosis

Earn 1.25 AMA PRA Category 1 Credit(s)™, 1.25 contact hours for...

IJMSC: Outdoor Adventure Programs for Persons with Multiple Sclerosis: A Review and Agenda for Future Research

Release Date: August 1, 2021 Valid for Credit Through: August...

Clinical Consultations™: SARS-CoV-2 Vaccination in Patients with MS – What Clinicians Need to Know Now

Release Date: June 29, 2021 Expiration Date: June 29, 2022...

IJMSC: CMSC Consensus Statement on Neurofilament Biomarkers in Multiple Sclerosis

This consensus document was developed by an international panel of...

IJMSC: Trekking Poles to Aid Multiple Sclerosis Walking Impairment: An Exploratory Comparison of the Effects of Assistive Devices on Psychosocial Impact and Walking

Release Date: June1, 2021 Valid for Credit Through: June 1,...

IJMSC: Variables Associated with Self-reported Language Impairment in Multiple Sclerosis: A Regression Analysis

Release Date: April1, 2021 Valid for Credit Through: April 1,...

Therapeutic Advances in the Management of Relapsing Forms of Multiple Sclerosis

Release Date: 3/12/2021 Expiration Date: 3/11/2022 Provider Statement This continuing...

AIMS Peer-to-Peer Podcasts

New Podcasts Available for Clinicians to Earn CE Credit! Earn...

IJMSC: Identifying Barriers to and Facilitators of Health Service Access Encountered by Individuals with Multiple Sclerosis

Release Date: February 1, 2021 Valid for Credit Through: February...

Multiple Sclerosis Management in Primary Care

Release Date: October 29, 2021 Expiration Date: October 28, 2022 Program Description...

ForuMS: Highlights from the 2021 CMSC Annual Meeting

Thursday, February 10, 2022 6:30 pm – 8:00 pm EST With...

CIS: Treating or Not Treating and with What?

DATE OF RELEASE/EXPIRATION The enduring material will be available from...

Young Latina MS Patient and Family Planning

DATE OF RELEASE/EXPIRATION The enduring material will be available from...

MANAGEMENT OF MS IN AFRICAN AMERICANS/BLACKS

DATE OF RELEASE/EXPIRATION The enduring material will be available from...

TREATMENT APPROACHES IN MS: CRITERIA FOR DECISION MAKING

DATE OF RELEASE/EXPIRATION The enduring material will be available from...

RACIAL AND GENETIC IMPLICATIONS FOR MS TREATMENT SELECTION

DATE OF RELEASE/EXPIRATION The enduring material will be available from...

Neuromyelitis Optica Spectrum Disorder: Modern Approaches to Diagnosis and Treatment

RELEASED ON: December 31, 2021EXPIRES ON: December 31, 2022This activity...

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 1: Fundamentals of Cannabis

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION...

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 2: Cannabis as an Herbal Medicine – Efficacy/Side Effect Considerations and Case Studies

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION...

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 3: Pharmacology and Interactions, Trial Data, DMTs, and Case Studies

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION...

Science and Self: Monitoring Response to MS Treatment with Biomarkers and Patient-Reported Outcomes

Release: 12/15/21 Expiration: 12/15/22 This activity is jointly provided by The...

Right Treatment, Right Time: A Comprehensive Curriculum on Individualized Treatment Approaches for Multiple Sclerosis

Released: December 1, 2021 Expires: December 1, 2022 An informative...

1,800 Seconds™ in Vaccines and MS Treatment

Release Date: October 7, 2021 Valid for Credit Through: October...

IJMSC: Evaluation of Treatment Practices for Urinalyses and Urine Cultures at an Outpatient Multiple Sclerosis Clinic

Release Date: October 1, 2021 Valid for Credit Through: October...

5-Part Podcast Series: Recent Clinical Updates in the Management of Multiple Sclerosis

Earn 1.25 AMA PRA Category 1 Credit(s)™, 1.25 contact hours for...

Clinical Consultations™: SARS-CoV-2 Vaccination in Patients with MS – What Clinicians Need to Know Now

Release Date: June 29, 2021 Expiration Date: June 29, 2022...

Therapeutic Advances in the Management of Relapsing Forms of Multiple Sclerosis

Release Date: 3/12/2021 Expiration Date: 3/11/2022 Provider Statement This continuing...

Multiple Sclerosis Management in Primary Care

Release Date: October 29, 2021 Expiration Date: October 28, 2022 Program Description...

A 3D Virtual Symposium Patient Considerations in MS: Achieving Optimal Outcomes Through an Individualized, Comprehensive Approach

Wednesday, February 16, 2022 7:00 PM (ET); 6:00 PM (CT);...

Multiple Sclerosis Management: Shedding Light on the Patient Perspective

Course opens: 12/20/2021 Course expires: 12/21/2022 Overview This activity, originally...

ForuMS: Highlights from the 2021 CMSC Annual Meeting

Thursday, February 10, 2022 6:30 pm – 8:00 pm EST With...

CIS: Treating or Not Treating and with What?

DATE OF RELEASE/EXPIRATION The enduring material will be available from...

Young Latina MS Patient and Family Planning

DATE OF RELEASE/EXPIRATION The enduring material will be available from...

MANAGEMENT OF MS IN AFRICAN AMERICANS/BLACKS

DATE OF RELEASE/EXPIRATION The enduring material will be available from...

TREATMENT APPROACHES IN MS: CRITERIA FOR DECISION MAKING

DATE OF RELEASE/EXPIRATION The enduring material will be available from...

RACIAL AND GENETIC IMPLICATIONS FOR MS TREATMENT SELECTION

DATE OF RELEASE/EXPIRATION The enduring material will be available from...

Neuromyelitis Optica Spectrum Disorder: Modern Approaches to Diagnosis and Treatment

RELEASED ON: December 31, 2021EXPIRES ON: December 31, 2022This activity...

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 1: Fundamentals of Cannabis

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION...

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 2: Cannabis as an Herbal Medicine – Efficacy/Side Effect Considerations and Case Studies

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION...

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 3: Pharmacology and Interactions, Trial Data, DMTs, and Case Studies

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION...

Science and Self: Monitoring Response to MS Treatment with Biomarkers and Patient-Reported Outcomes

Release: 12/15/21 Expiration: 12/15/22 This activity is jointly provided by The...

Right Treatment, Right Time: A Comprehensive Curriculum on Individualized Treatment Approaches for Multiple Sclerosis

Released: December 1, 2021 Expires: December 1, 2022 An informative...

IJMSC: NARCOMS and Other Registries in Multiple Sclerosis: Issues and Insights

Release Date: December 1, 2021 Valid for Credit Through: December...

Novel Treatment: Upgrading the Standard of Care for Neuromyelitis Optica Spectrum Disorder (NMOSD)

RELEASE DATE: November 18, 2021 EXPIRATION DATE: November 18, 2022 FACULTY Dean...

1,800 Seconds™ in Vaccines and MS Treatment

Release Date: October 7, 2021 Valid for Credit Through: October...

IJMSC: Evaluation of Treatment Practices for Urinalyses and Urine Cultures at an Outpatient Multiple Sclerosis Clinic

Release Date: October 1, 2021 Valid for Credit Through: October...

Medical Minute: Influence of Sleep Disturbances and Obesity on MS and Associated Symptoms

Physicians: maximum of 0.5 AMA PRA Category 1 Credits™Registered Nurses:...

Medical Minute: Influence of Anxiety and Depression on MS and Associated Symptoms

Physicians: maximum of 0.5 AMA PRA Category 1 Credits™Registered Nurses:...

The Importance of Managing Fatigue in Multiple Sclerosis

Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered...

5-Part Podcast Series: Recent Clinical Updates in the Management of Multiple Sclerosis

Earn 1.25 AMA PRA Category 1 Credit(s)™, 1.25 contact hours for...

IJMSC: Outdoor Adventure Programs for Persons with Multiple Sclerosis: A Review and Agenda for Future Research

Release Date: August 1, 2021 Valid for Credit Through: August...

Clinical Consultations™: SARS-CoV-2 Vaccination in Patients with MS – What Clinicians Need to Know Now

Release Date: June 29, 2021 Expiration Date: June 29, 2022...

IJMSC: CMSC Consensus Statement on Neurofilament Biomarkers in Multiple Sclerosis

This consensus document was developed by an international panel of...

IJMSC: Trekking Poles to Aid Multiple Sclerosis Walking Impairment: An Exploratory Comparison of the Effects of Assistive Devices on Psychosocial Impact and Walking

Release Date: June1, 2021 Valid for Credit Through: June 1,...

IJMSC: Variables Associated with Self-reported Language Impairment in Multiple Sclerosis: A Regression Analysis

Release Date: April1, 2021 Valid for Credit Through: April 1,...

Therapeutic Advances in the Management of Relapsing Forms of Multiple Sclerosis

Release Date: 3/12/2021 Expiration Date: 3/11/2022 Provider Statement This continuing...

AIMS Peer-to-Peer Podcasts

New Podcasts Available for Clinicians to Earn CE Credit! Earn...

IJMSC: Identifying Barriers to and Facilitators of Health Service Access Encountered by Individuals with Multiple Sclerosis

Release Date: February 1, 2021 Valid for Credit Through: February...

AOTA

No posts found!

APA

CIS: Treating or Not Treating and with What?

DATE OF RELEASE/EXPIRATION The enduring material will be available from...

Young Latina MS Patient and Family Planning

DATE OF RELEASE/EXPIRATION The enduring material will be available from...

MANAGEMENT OF MS IN AFRICAN AMERICANS/BLACKS

DATE OF RELEASE/EXPIRATION The enduring material will be available from...

TREATMENT APPROACHES IN MS: CRITERIA FOR DECISION MAKING

DATE OF RELEASE/EXPIRATION The enduring material will be available from...

RACIAL AND GENETIC IMPLICATIONS FOR MS TREATMENT SELECTION

DATE OF RELEASE/EXPIRATION The enduring material will be available from...

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 1: Fundamentals of Cannabis

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION...

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 2: Cannabis as an Herbal Medicine – Efficacy/Side Effect Considerations and Case Studies

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION...

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 3: Pharmacology and Interactions, Trial Data, DMTs, and Case Studies

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION...

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 1: Fundamentals of Cannabis

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION...

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 2: Cannabis as an Herbal Medicine – Efficacy/Side Effect Considerations and Case Studies

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION...

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 3: Pharmacology and Interactions, Trial Data, DMTs, and Case Studies

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION...